Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009 - Wikidata - awgldk - TriplyDB

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009

http://www.wikidata.org/entity/Q30400049

about

Influenza prevention and treatment in transplant recipients and immunocompromised hosts Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance Exhaled air dispersion during coughing with and without wearing a surgical or N95 mask Impact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling study Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Antivirals in the 2009 pandemic--lessons and implications for future strategies.Two years after pandemic influenza A/2009/H1N1: what have we learned?Drug resistance in influenza A virus: the epidemiology and management.A Narrative Review of Influenza: A Seasonal and Pandemic Disease.New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.An outbreak of the 2009 influenza a (H1N1) virus in a children's hospital.Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance Fitness of neuraminidase inhibitor-resistant influenza A viruses Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus.Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.Generation of Adaptive Immune Responses Following Influenza Virus Challenge is Not Compromised by Pre-Treatment with the TLR-2 Agonist Pam2Cys Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.Deep sequencing: becoming a critical tool in clinical virology.Isolation precautions for visitors.Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.Assessing the reporting quality of influenza outbreaks in the community.

P2860

Q27011595-49F43B89-34F3-4152-B5C0-2FD109B583D9 Q28282405-1FD4163C-D54A-4ADF-B505-B67E06BA1813 Q28391822-89C6426D-E6FC-47CC-B1D7-62C45928AF78 Q28537982-99B638CD-A0FB-4662-98A9-6014EF992330 Q28541953-417F9F90-60CB-4FA6-A882-184A34E09F2B Q30202859-742F2DC7-25DA-42D0-8145-2BD8825FC8CE Q30219151-FD678ECB-DC7A-4C16-9B41-86A4B156E88A Q30224656-95EC15F5-5363-45AA-ADF1-D8B54FCD300D Q30234600-341143D1-9C57-40C0-9F78-3FDBADC2A1A7 Q30235281-19DBC153-72F7-4055-A4B0-2653592CBF20 Q30355297-1D115999-3F74-47E4-B790-DD7AD2DED268 Q30356466-ADEDA989-CB4D-4E4F-A4B9-E6F89CF846B0 Q30367861-FCAB9126-7367-4A72-8CEE-5F030391F917 Q30370942-D805D4B8-7DD7-4DD0-ADA6-2DAF0944D648 Q30390145-24B06E45-E90C-476F-BAD6-1DB77D80698A Q30403699-0AAF052A-9A8A-4952-8C87-1C83D222EC1A Q30407946-12CE836F-370F-407F-90B4-B51D13BBE003 Q30411233-A719E473-BBEC-422F-AF6B-7414615DA52C Q30413246-97B51188-D3DE-4A93-9B09-64F8001D1D47 Q30414559-EEC520DE-2C95-44E8-87CC-6BEB8E53EB5A Q30415228-75736278-0AA0-4AA7-8CBF-597089530B83 Q30416440-57945224-E3F2-418D-A5FA-FF1225ACB2DF Q30419391-FD9DC14D-56AF-4110-A7A9-5A2AA09E6C2D Q30420892-2DF8D04D-1AFC-4513-9572-E77C7ECC5B4F Q30422779-81DA4BF8-6A14-4B64-BA2F-30306A5CCCBA Q30423023-D5E512F8-83E0-4EC9-B158-6F863D3F6FE7 Q30428311-D4917C7D-5577-4C5D-A851-2949F7B11965 Q35687079-A67F20EF-6EC6-45D2-B52D-0A2514229331 Q36048315-B022EC4B-851E-464B-8315-A8C0246297DC Q36965855-1A50C697-5141-4452-9D0A-5BE471166647 Q38209673-BADDA357-1897-4A7C-9791-389907D8A68D Q38226696-07F8319C-12A1-44A3-AC77-B08E92E936D1 Q38504662-3FD36DCA-9022-4965-BEDE-CD6A0439B73E Q40289037-495008FF-838A-49CF-A898-BCB4B2073D28 Q40509650-9BEFCBEA-2DAF-428B-B34D-643591D226D0 Q47114544-E5D34062-C24A-4583-AD57-FBF53BE377F6

P2860

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009

http://www.wikidata.org/entity/Q30400049

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@ast

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@en

type

label

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@ast

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@en

prefLabel

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@ast

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@en

P1433

Q30400049-8CC02674-6A38-41A5-A5DF-4B9804250805

P1476

Q30400049-C53BCD49-09EB-467C-B09B-99120ED1E3C5

P2093

Q30400049-0DC20E85-1E82-4B63-BDDC-6D3D1F489F0D

Q30400049-2A63808D-B04D-4B44-B785-6E88F258CB29

Q30400049-2DDF992A-506A-4C67-B204-432C2E52AA8B

Q30400049-40AEC216-4D0E-4B52-BBD7-5B556475C764

Q30400049-7BFBC123-5A61-41B3-AA8C-A95830A8D590

Q30400049-99968F5F-8211-4E4F-8E78-350EB82DE1DB

Q30400049-9A654869-DDBF-4D81-B23A-207C8A30CB5C

Q30400049-A3A212E9-3E1D-4F20-8F6E-4B295981023D

Q30400049-A790103B-C249-405C-B122-CFA1A51B5202

Q30400049-D36F4CA0-DC18-4E3C-B557-83335C079324

P2860

Q30400049-019280DD-4D60-4218-AC21-68110B366252

Q30400049-056934BC-6F1C-4FCA-A586-13769BCAE515

Q30400049-0D2C2ADA-A31F-4D13-AEC8-33FB8CECDBF3

Q30400049-16452B65-ABB6-4DB0-899C-E6A8A010AFD8

Q30400049-1A99914E-ADA0-4AA0-8D27-C81E6AE667DA

Q30400049-372F86CC-E814-4B61-AB18-3B665BE8F73E

Q30400049-37F152E0-7FB8-40ED-B016-98B1DFB1D881

Q30400049-5ED62F51-FA3B-4521-BCEF-A3D342E24D07

Q30400049-76860762-5775-4325-8F0C-C9AC1A0266F2

Q30400049-7A50B6AE-AAF8-4667-906A-4A73E7213F1E

P304

Q30400049-08C3809F-DABF-4B39-AFCC-396704E0E339

P31

Q30400049-68C41DF6-8E81-4C6E-880B-83955DF63980

P356

Q30400049-4020169E-AE02-4379-B1B6-146B3B7319E6

P407

Q30400049-6E72E41D-1084-4284-89F6-832CD73B7E93

P433

Q30400049-9DF7EC45-ED59-4C1B-BDDB-84AF87000C75

P478

Q30400049-DF004882-5490-4EAC-A51A-B148CB5E60D8

P50

Q30400049-31E36B11-5C26-4A6B-9C68-6DEBE0C2E6E7

Q30400049-A17A237E-8F90-426B-81CF-7564BB6FD649

Q30400049-CB686574-EA7E-465F-9CCF-D5BDFC5CB706

P577

Q30400049-2BF76B03-9BC5-45CE-84C3-2AABA7D407EC

P5875

Q30400049-EF833B9B-F72F-40A9-8306-A517BA73D083

P698

Q30400049-424498BC-5D66-439C-97A4-829C9FB43FC7

P921

Q30400049-814E9D1C-9FCA-4646-AC8A-C170F746494D

P932

Q30400049-8FFE118E-2C3C-4782-8812-0F0031D2B337

P356

P1433

The Journal of Infectious Diseases

P1476

Cluster of oseltamivir-resista ...... patients--North Carolina, 2009

@en

P2093

Aaron T Fleischauer

http://www.w3.org/2001/XMLSchema#string

Agam K Rao

http://www.w3.org/2001/XMLSchema#string

Arjun Srinivasan

http://www.w3.org/2001/XMLSchema#string

Cameron R Wolfe

http://www.w3.org/2001/XMLSchema#string

Ian Greenwald

http://www.w3.org/2001/XMLSchema#string

Jonathan Duffy

http://www.w3.org/2001/XMLSchema#string

Larisa V Gubareva

http://www.w3.org/2001/XMLSchema#string

Luke F Chen

http://www.w3.org/2001/XMLSchema#string

Natalie J M Dailey

http://www.w3.org/2001/XMLSchema#string

Varough M Deyde

http://www.w3.org/2001/XMLSchema#string

P2860

TreeView: an application to display phylogenetic trees on personal computers

Swine influenza A (H1N1) infection in two children--Southern California, March-April 2009

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.

Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

P304

838-846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIQ124

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

Deverick J. Anderson

Daniel J Sexton

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49856751

http://www.w3.org/2001/XMLSchema#string

P698

21343149

http://www.w3.org/2001/XMLSchema#string

P921

P932

3307091

http://www.w3.org/2001/XMLSchema#string